Can live Bacillus licheniformis capsules treat ulcerative colitis?

Bacillus licheniformis live capsule may serve as an adjunctive treatment for ulcerative colitis, but it cannot directly cure the disease.

Bacillus licheniformis live capsule is a probiotic preparation, whose main components include lyophilized Enterococcus faecalis and Enterococcus faecium. Its primary functions are regulating gastrointestinal flora, alleviating diarrhea, reducing inflammation, and eliminating bacteria. These probiotics can regulate the balance of intestinal flora, improve intestinal function, and help maintain intestinal health. However, ulcerative colitis is a chronic nonspecific inflammatory bowel disease, whose pathogenesis is related to genetic, immune, environmental, and intestinal microbial factors. Therefore, simply regulating the gut microbiota cannot directly treat ulcerative colitis.

As a probiotic preparation, Bacillus licheniformis live capsule cannot directly cure ulcerative colitis, but it can aid in treatment by helping to restore the normal intestinal flora structure, reduce intestinal inflammatory responses, improve patients' digestive and absorptive functions, and enhance their quality of life.

Currently, there is no radical cure for ulcerative colitis. Clinical treatment focuses on controlling symptoms and maintaining remission. Commonly used medications include glucocorticoids, 5-aminosalicylic acid preparations, and immunosuppressants. Treatment for this disease usually requires a comprehensive approach including dietary adjustments, medication, and surgery.

Therefore, Bacillus licheniformis live capsule has a certain adjunctive therapeutic effect on ulcerative colitis, but cannot directly cure the disease. Patients should undergo comprehensive treatment under the guidance of a physician.